Scorpion Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
October 26, 2020
Vertical
Biotechnology
Funding Amount
$108,000,000
Company Info
Founders
Gary D. Glick
Market
Precision Oncology
Location
Boston, MA, USA
Coinvestors
Abingworth, Atlas Venture, Omega Funds, Partners HealthCare Innovation, Vida Ventures
Company Description

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.